Centre de Recherche Dermatologique du Quebec Metropolitan

Québec, Quebec G1V 4X7

0 studies enrolling now · 3 studies all time

What they study most

Dermatitis, Atopic, Hidradenitis Suppurativa, Papulopustular Rosacea

Studies at this site

• A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa — Stopped early
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• Phase 3 Papulopustular Rosacea Study — Completed